Business

Appendix 4E and 2026 Annual Report

Appendix 4E and 2026 Annual Report

Argent Biopharma LtdAugust 31, 20265
Appendix 4E and 2026 Annual Report

About this update from Argent Biopharma Ltd

Argent Biopharma Ltd has released a press release. View Attachment

View stock analysis, news, and events for Argent Biopharma Ltd

More from Argent Biopharma Ltd

FDA-CVM Establish INAD File for CannEpil Veterinary Program

August 25, 2026

US Veterinary Development Programme for CannEpil Commences

August 5, 2026

All Argent Biopharma Ltd news →